Valuation: OssDsign AB (publ)

Market Cap 389M 38.82M 34.26M 32.41M 29.4M 55.11M 3.73B 55.66M 150M 1.9B 146M 143M 6.12B P/E 2026 *
-8.27x
P/E 2027 * -10.8x
Enterprise Value 271M 27.09M 23.91M 22.62M 20.51M 38.46M 2.6B 38.84M 105M 1.33B 102M 99.51M 4.27B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.4x
Free-Float
75.42%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 31/12/2025
Director of Finance/CFO 63 31/12/2019
Chief Tech/Sci/R&D Officer 47 31/12/2021
Director TitleAgeSince
Chairman 66 19/04/2016
Director/Board Member 60 31/12/2021
Director/Board Member 61 24/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 38.55M
+1.26%+1.34%-24.63%+2.01% 106B
-0.10%-1.84%-23.60%-1.12% 11.29B
-0.01%-0.82%+95.07%+110.70% 9.35B
+0.33%-1.52%-49.54%-67.02% 4.11B
-1.79%-0.02%-24.09%+24.68% 2.49B
+4.54%+2.64%-3.21%-63.12% 2.02B
-0.20%-4.27% - - 1.9B
-0.58%-2.03%-22.53%-32.61% 1.52B
Average -3.63%-0.94%-7.51%-3.78% 17.29B
Weighted average by Cap. +0.98%+0.66%-16.74%+6.18%

Financials

2026 *2027 *
Net sales 160M 15.92M 14.05M 13.3M 12.06M 22.61M 1.53B 22.83M 61.47M 780M 59.79M 58.49M 2.51B 234M 23.32M 20.58M 19.47M 17.66M 33.1M 2.24B 33.43M 90.01M 1.14B 87.55M 85.65M 3.68B
Net income -46.8M -4.67M -4.12M -3.9M -3.54M -6.63M -448M -6.7M -18.04M -229M -17.54M -17.16M -737M -35.3M -3.52M -3.11M -2.94M -2.67M -5M -338M -5.05M -13.6M -173M -13.23M -12.95M -556M
Net Debt -118M -11.73M -10.35M -9.79M -8.88M -16.65M -1.13B -16.82M -45.29M -575M -44.05M -43.09M -1.85B -61M -6.09M -5.37M -5.08M -4.61M -8.65M -584M -8.73M -23.51M -298M -22.87M -22.37M -960M
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
41
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-